CA2250780A1 — Correction of genetic defects using chemical chaperones
Assigned to University of California San Diego UCSD · Expires 1997-10-16 · 29y expired
What this patent protects
A method for stabilizing intracellular proteins known to cause disease, said method comprising contacting a cell with stabilizing agents such as DMSO, sugars, amino acids and TMAO, wherein the proteins are stabilized and the disease state lessened.
USPTO Abstract
A method for stabilizing intracellular proteins known to cause disease, said method comprising contacting a cell with stabilizing agents such as DMSO, sugars, amino acids and TMAO, wherein the proteins are stabilized and the disease state lessened.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.